These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 9649125)

  • 1. Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.
    Favoni RE; de Cupis A; Bruno S; Yee D; Ferrera A; Pirani P; Costa A; Decensi A
    Br J Cancer; 1998 Jun; 77(12):2138-47. PubMed ID: 9649125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
    Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
    Kazmi SM; Plante RK; Visconti V; Lau CY
    Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.
    Sheikh MS; Shao ZM; Li XS; Ordonez JV; Conley BA; Wu S; Dawson MI; Han QX; Chao WR; Quick T
    Carcinogenesis; 1995 Oct; 16(10):2477-86. PubMed ID: 7586155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2L.
    Anding AL; Jones JD; Newton MA; Curley RW; Clagett-Dame M
    Anticancer Res; 2018 Aug; 38(8):4403-4416. PubMed ID: 30061204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cells.
    Kawamura I; Lacey E; Mizota T; Tsujimoto S; Nishigaki F; Manda T; Shimomura K
    Anticancer Res; 1994; 14(2A):427-31. PubMed ID: 8017842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of tamoxifen or interferon-beta and 4-hydroxyphenylretinamide on the growth of breast cancer cell lines.
    Coradini D; Biffi A; Pellizzaro C; Pirronello E; Di Fronzo G
    Tumour Biol; 1997; 18(1):22-9. PubMed ID: 8989922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(4-hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells.
    Herbert BS; Sanders BG; Kline K
    Nutr Cancer; 1999; 34(2):121-32. PubMed ID: 10578478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental studies on the effects of the combined use of N-(4-hydroxyphenyl)retinamide (4-HPR) and tamoxifen (TAM) for estrogen receptor (ER)-negative breast cancer.
    Aoyama Y
    Kurume Med J; 2002; 49(1-2):27-33. PubMed ID: 12235869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
    J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
    Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
    Ohlmann CH; Jung C; Jaques G
    Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
    Iida M; Tsuboi K; Niwa T; Ishida T; Hayashi SI
    Breast Cancer; 2019 May; 26(3):272-281. PubMed ID: 30328006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
    Arteaga CL; Osborne CK
    Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.
    Patel JB; Mehta J; Belosay A; Sabnis G; Khandelwal A; Brodie AM; Soprano DR; Njar VC
    Br J Cancer; 2007 Apr; 96(8):1204-15. PubMed ID: 17387344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
    Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
    J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
    Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of breast cancer growth by insulin-like growth factors.
    Osborne CK; Clemmons DR; Arteaga CL
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):805-9. PubMed ID: 2178363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl) retinamide.
    Pellegrini R; Mariotti A; Tagliabue E; Bressan R; Bunone G; Coradini D; Della Valle G; Formelli F; Cleris L; Radice P
    Cell Growth Differ; 1995 Jul; 6(7):863-9. PubMed ID: 7547508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.